2026年更新的抗菌的发现和设计的计算方法
Guillermin Agüero-Chapin1,2, Agostinho Antunes1,2, Yovani Marrero-Ponce3,4
1CIIMAR/CIMAR LA, Interdisciplinary Centre of Marine and Environmental Research, University of Porto, 4450-208 Porto, Portugal.
Antibiotics (Basel, Switzerland)
|February 27, 2026
概括
抗菌素耐药性 (AMR) 是全球主要的健康威胁. 需要新的策略来对抗耐药性感染,并保持现有治疗的有效性.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 抗菌素耐药性 (AMR) 构成了对全球健康的重大和日益严重的威胁.
- 耐药病原体的出现和传播使治疗复杂化,死亡率增加.
- 迫切需要采取行动,以应对AMR的多方面的挑战.
研究的目的:
- 审查当前抗微生物药物耐药性的情况.
- 突出AMR的关键挑战和新兴趋势.
- 讨论对抗AMR的潜在策略.
主要方法:
- 关于抗菌素耐药性的最新研究的综合文献综述.
- 对抗性病原体的全球监测数据的分析.
- 综合有关新型抗菌剂和替代疗法的信息.
主要成果:
- 在各种临床环境中,多种耐药生物体的流行率不断增加.
- 新抗生素的管道有限,加剧了耐药性危机.
- 目前的感染预防和控制措施的有效性各不相同.
结论:
- 一个协调的全球方法对于打击AMR至关重要.
- 投资于研究和开发新的抗微生物药物和诊断手段至关重要.
- 管理计划和公众宣传活动对于保持抗生素疗效至关重要.
相关概念视频
Drug Discovery: Overview
12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K


